Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer

Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK
Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer ( Prof Joe M O'Sullivan - Queen's University Belfast, Belfast, UK )
17 Feb 2023

JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma

Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada
JAVELIN Bladder 100: Avelumab maintenance indicated as a standard of care for advanced urothelial carcinoma ( Dr Srikala Sridhar - Princess Margaret Cancer Centre, Ontario, Canada )
16 Feb 2023

Stereotactic body radiotherapy compared with surgery for localised prostate cancer

Dr Nicholas John van As - The Royal Marsden NHS Foundation Trust, London, UK
Stereotactic body radiotherapy compared with surgery for localised prostate cancer ( Dr Nicholas John van As - The Royal Marsden NHS Foundation Trust, London, UK )
16 Feb 2023

Changes in planned disease management after PET/CT in men with biochemically recurrent prostate cancer and low PSA levels

Dr Frédéric Pouliot - Université Laval, Quebec, Canada
Changes in planned disease management after PET/CT in men with biochemically recurrent prostate cancer and low PSA levels ( Dr Frédéric Pouliot - Université Laval, Quebec, Canada )
16 Feb 2023

Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may improve PFS and MFS after prostatectomy

Prof Paul L Nguyen - Dana-Farber Cancer Institute, Boston, USA
Abiraterone acetate/prednisone + apalutimide and ADT with post-op SRT may improve PFS and MFS after prostatectomy ( Prof Paul L Nguyen - Dana-Farber Cancer Institute, Boston, USA )
16 Feb 2023

Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma

Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA
Safety and efficacy of immune checkpoint inhibitors in advanced penile squamous cell carcinoma ( Dr Talal El Zarif - Dana-Farber Cancer Institute, Boston, USA )
16 Feb 2023

HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer

Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain
HER2DX: a new diagnostic tool for early-stage HER2 positive breast cancer ( Prof Aleix Prat - Hospital Clínic Barcelona, Barcelona, Spain )
7 Feb 2023

L'importance de choisir judicieusement les médicaments anticancéreux

Prof Moctar Toure - University Hospital Medical Center at Treichville, Abidjan, Côte d'Ivoire
L'importance de choisir judicieusement les médicaments anticancéreux ( Prof Moctar Toure -  University Hospital Medical Center at Treichville, Abidjan, Côte d'Ivoire )
7 Feb 2023

L'importance de choisir judicieusement en oncologie chirurgicale

Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal
L'importance de choisir judicieusement en oncologie chirurgicale ( Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal )
7 Feb 2023

Choosing Wisely in haemato oncology and medical oncology

Dr Omar Hamid - Garissa Cancer Center, Garissa, Kenya
Choosing Wisely in haemato oncology and medical oncology ( Dr Omar Hamid - Garissa Cancer Center, Garissa, Kenya )
7 Feb 2023

Choosing Wisely in haemato-medical oncology

Dr Omar Hamid - Garissa Cancer Centre, Garissa, Kenya
Choosing Wisely in haemato-medical oncology ( Dr Omar Hamid - Garissa Cancer Centre, Garissa, Kenya )
7 Feb 2023

Choisir judicieusement en oncologie chirurgicale

Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal
Choisir judicieusement en oncologie chirurgicale ( Prof Sidy Ka - Cheikh Anta Diop University, Dakar, Senegal )
7 Feb 2023